Efficacy of defroxamine- deferiprone on cardiac function of patients with major thalassemia

Autor: Mirbehbahani NB, Nikyar B, Behnampour N, Rashidbaghan A, Kiani M, Nikyar A

Publikováno v: مجله دانشگاه علوم پزشکی گرگان, Vol 17, Iss 3, Pp 96-100 (2015)

Background and Objective: Deferoxamin is the current “gold standard” chelator in comparison with new chelators. Combined therapy of Deferiprone and deferoxamin reduces the cardiac iron overload in patients with major talassemia. This study was do

Externí odkaz: https://doaj.org/article/a607377320a84ae99629c73065e5fb37

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ethnical variations in the incidence of congenital heart defects in gorgan, northern iran: a single-center study.

Autor: Nikyar B; Gorgan Congenital Malformations Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Sedehi M; Gorgan Congenital Malformations Research Center, Golestan University of Medical Sciences, Gorgan, Iran., Qorbani M; Department of Public Health, Alborz University of Medical Sciences, Karaj, Iran . ; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran ., Nikyar A; Cranfield University, London, England., Golalipour MJ; Gorgan Congenital Malformations Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Publikováno v: The journal of Tehran Heart Center [J Tehran Heart Cent] 2014 Jan 12; Vol. 9 (1), pp. 9-14.